Stanford's John H. Stevens, M.D., Joins Heartport as Chief Technical Officer; Will Play Key Role in Company's New Technology Development Initiatives.REDWOOD CITY, Calif.--(BW HealthWire)--July 3, 1997--Heartport, Inc. (NASDAQ NASDAQ in full National Association of Securities Dealers Automated Quotations U.S. market for over-the-counter securities. Established in 1971 by the National Association of Securities Dealers (NASD), NASDAQ is an automated quotation system that reports on :HPRT HPRT Hypoxanthine-guanine phosphoribosyl transferase, see there ), announced today that John H. Stevens
"Dr. Stevens' experience as a practicing heart surgeon has been key to Heartport's development of the Port-Access systems for minimally invasive cardiac surgery minimally invasive cardiac surgery Interventional cardiology Any of a number of techniques–MIDCAB, off-pump coronary-artery bypass, minimally invasive valve surgery, port-access coronary surgery, and port-access valve surgery–increasingly being used to ," said Wesley D. Sterman, M.D., Heartport's president and chief executive officer. "John's decision to devote his expertise and talents full-time to Heartport will help the company both to expand its current technology and to develop additional new technologies." Dr. Stevens founded Heartport along with Dr. Sterman in 1991 and has been a director of the company since that time. As Assistant Professor of Cardiothoracic Surgery at Stanford University School of Medicine, Dr. Stevens' practice comprised both pediatric pediatric /pe·di·at·ric/ (pe?de-at´rik) pertaining to the health of children. pe·di·at·ric adj. Of or relating to pediatrics. and adult cardiac surgery. He performed Port-Access coronary artery bypass grafting and Port-Access heart valve replacement Heart Valve Replacement Definition Heart valve replacement is a surgical procedure during which surgeons remove a damaged valve from the heart and substitute a healthy one. and repair procedures during the initial clinical trials and on a regular basis since the company launched its Port-Access minimally invasive cardiac surgery systems earlier this year. "Heartport has only just introduced a new platform that I believe will have a major impact on heart disease," said Dr. Stevens. "I am excited to focus full-time on helping Heartport further refine its current technology and develop additional technology for the treatment of heart disease." Previously, Dr. Stevens was Chief Resident of the Department of Cardiothoracic Surgery at the Stanford University School of Medicine, and Senior Registrar in Cardiothoracic Surgery at the Great Ormond Street Hospital The Great Ormond Street Hospital for Children (GOSH) was founded in London in 1852. There are a few institutions which pre-date it as providing care for children, although not in-patient beds. for Sick Children in London, England. Dr. Stevens earned B.U.S. and B.S. degrees in communications and psychology from the University of Utah and an M.D. from Stanford University School of Medicine. He has published numerous articles in leading medical journals and contributed chapters to several surgical textbooks. Heartport, Inc., is a cardiovascular device company advancing the frontiers of cardiac surgery by developing, manufacturing, and marketing Port-Access minimally invasive cardiac surgery systems for major heart surgery. The Company's Port-Access Systems are designed to allow surgeons to perform a wide range of heart operations through small incisions, or "ports," between the ribs, without the need to crack open the chest as is required in conventional heart surgery. CONTACT: Heartport, Inc. Jim Weiss, 415/482-4430 |
|
||||||||||||||
Printer friendly
Cite/link
Email
Feedback
Reader Opinion